Success Metrics

Clinical Success Rate
96.4%

Based on 27 completed trials

Completion Rate
96%(27/28)
Active Trials
3(7%)
Results Posted
41%(11 trials)
Terminated
1(2%)

Phase Distribution

Ph early_phase_1
1
2%
Ph phase_1
3
7%
Ph phase_4
8
19%
Ph not_applicable
6
14%
Ph phase_2
9
21%
Ph phase_3
8
19%

Phase Distribution

4

Early Stage

9

Mid Stage

16

Late Stage

Phase Distribution35 total trials
Early Phase 1First-in-human
1(2.9%)
Phase 1Safety & dosage
3(8.6%)
Phase 2Efficacy & side effects
9(25.7%)
Phase 3Large-scale testing
8(22.9%)
Phase 4Post-market surveillance
8(22.9%)
N/ANon-phased studies
6(17.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.1%

27 of 29 finished

Non-Completion Rate

6.9%

2 ended early

Currently Active

3

trials recruiting

Total Trials

43

all time

Status Distribution
Active(3)
Completed(27)
Terminated(2)
Other(11)

Detailed Status

Completed27
unknown11
Recruiting3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
43
Active
3
Success Rate
96.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.9%)
Phase 13 (8.6%)
Phase 29 (25.7%)
Phase 38 (22.9%)
Phase 48 (22.9%)
N/A6 (17.1%)

Trials by Status

completed2763%
terminated12%
recruiting37%
withdrawn12%
unknown1126%

Recent Activity

Clinical Trials (43)

Showing 20 of 43 trialsScroll for more
NCT03117010

Prospective Cohort for Adult Hemophagocytosis

Recruiting
NCT07320612Phase 1

Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome

Completed
NCT03939637Phase 3

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Completed
NCT05403359

StEroids in hospitaLized patiEnts With Covid-19 in The Netherlands.

Completed
NCT06732622Not Applicable

Laser Acupuncture for Idiopathic Bell's Palsy

Recruiting
NCT06280794Not Applicable

Efficacy of Laser Acupuncture for Idiopathic Bell's Palsy

Recruiting
NCT05702879

Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success

Unknown
NCT06133192Phase 2

Steroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHD

Unknown
NCT02188368Phase 2

Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients

Terminated
NCT02133924Phase 2

Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

Completed
NCT02619552

Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease

Completed
NCT03460847

Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa

Completed
NCT00377962Phase 4

Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

Completed
NCT03852355Not Applicable

the Effectiveness of 3rd Occipital Radiofrequency Versus Systemic Steroid in Headache Management in Rheumatoid Arthritis

Completed
NCT03091010Not Applicable

A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.

Unknown
NCT00272350Phase 1

ZD6474 to Treat Advanced Brain Cancer in Patients

Completed
NCT04113915

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

Unknown
NCT04025476

Immune Profile of Acute VKH Patients PBMC

Unknown
NCT02084446Phase 4

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

Completed
NCT03202836Not Applicable

Vaginal Progesterone Supplementation in the Management of Preterm Labor

Completed

Drug Details

Intervention Type
DRUG
Total Trials
43